Determinants of quinolone resistance in Escherichia coli causing community-acquired urinary tract infection in Bejaia, Algeria

被引:27
作者
Betitra, Yanat [1 ,2 ]
Teresa, Vinuesa [2 ]
Miguel, Vinas [2 ]
Abdelaziz, Touati [1 ]
机构
[1] Univ A MIRA Bejaia, Lab Ecol Microbiol, Bejaia 06000, Algeria
[2] Univ Barcelona, Sch Med, Dept Pathol & Expt Therapeut, Lab Mol Microbiol & Antibiot, E-08007 Barcelona, Spain
关键词
Escherichia coli; Community-acquired urinary tract infection; QRDR; Qnr; ESBL; SPECTRUM BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; EFFLUX PUMP; FLUOROQUINOLONE RESISTANCE; PLASMID; ENTEROBACTERIACEAE; GENE; PREVALENCE; WOMEN; QNRB;
D O I
10.1016/S1995-7645(14)60075-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To investigate the mechanisms of quinolone resistance and the association with other resistance markers among Esherichia coli(E. coli) strains isolated from outpatient with urinary tract infection in north of Algeria. Methods: A total of 30 nalidixic acid resistant E. coli isolates from outpatient with urinary tract infections from January 2010 to April 2011 in north of Algeria (Bejaia) were studied. Antimicrobial susceptibility was determined by disc diffusion assay, minimal inhibitory concentrations (MIC) of quinolone were determined by microdilution. Mutations in the Quinolone Resistance-Determining Region (QRDR) of gyrA and parC genes and screening for qnr (A, B and S) and bla genes were done by PCR and DNA sequencing. Results: Most of the E. coli isolates (56.66%) were shown to carry mutations in gyrA and parC (gyrA: Ser83Leu + Asp87Asn and parC:Ser80Ile). While, 16.66% had only an alteration in g)tA: Ser83Leu. One isolate produced qnrB like and two qnrS-like. Four isolates were CTX-M-15 producers associated with TEM-1 producing in one case. Co-expression of bla(crx-m-15) and qnrB was determined in one E. coli isolate. Conclusions: Our findings suggested the community emergence of gyrA and parC alterations and QnrB determinants that contributed to the development and spread of fluoroquinolone resistance in Algerian E. coli isolates.
引用
收藏
页码:462 / 467
页数:6
相关论文
共 35 条
[1]   Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK [J].
Amin, Amit K. ;
Wareham, David W. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (05) :490-491
[2]  
[Anonymous], 2011, Performance standards for antimicrobial disk susceptibility tests
[3]  
approved standard M2-A11, V11th
[4]   Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates [J].
Bansal, Sandhya ;
Tandon, Vibha .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (03) :253-255
[5]   Evidence of an efflux pump in Serratia marcescens [J].
Berlanga, M ;
Vázquez, JL ;
Hernandez-Borrell, J ;
Montero, MT ;
Viñas, M .
MICROBIAL DRUG RESISTANCE, 2000, 6 (02) :111-117
[6]  
Bouchakour M, 2010, J INFECT DEV COUNTR, V4, P799
[7]   Incidence of class A extended-spectrum β-lactamases in Champagne-Ardenne (France):: a 1 year prospective study [J].
Brasme, L. ;
Nordmann, P. ;
Fidel, F. ;
Lartigue, M. F. ;
Bajolet, O. ;
Poirel, L. ;
Forte, D. ;
Vernet-Garnier, V. ;
Madoux, J. ;
Reveil, J. C. ;
Alba-Sauviat, C. ;
Baudinat, I. ;
Bineau, P. ;
Bouquigny-Saison, C. ;
Eloy, C. ;
Lafaurie, C. ;
Simeon, D. ;
Verquin, J. P. ;
Noel, F. ;
Strady, C. ;
De Champs, C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) :956-964
[8]   In Vitro Effect of qnrA1, qnrB1, and qnrS1 Genes on Fluoroquinolone Activity against Isogenic Escherichia coli Isolates with Mutations in gyrA and parC [J].
Briales, A. ;
Rodriguez-Martinez, J. M. ;
Velasco, C. ;
Diaz de Alba, P. ;
Dominguez-Herrera, J. ;
Pachon, J. ;
Pascual, A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) :1266-1269
[9]   qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin [J].
Cavaco, L. M. ;
Hasman, H. ;
Xia, S. ;
Aarestrup, F. M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) :603-608
[10]  
Deepak RN, 2009, ANN ACAD MED SINGAP, V38, P1070